Posterior Inferior Cerebellar Artery-Posterior Inferior Cerebellar Artery Bypass versus Occipital Artery-Posterior Inferior Cerebellar Artery Bypass for Treating Posterior Circulation Aneurysms: A Systematic Review and Comparative Meta-Analysis

Pica(排版) 小脑后下动脉 医学 枕动脉 外科 动脉瘤 吻合 计算机科学 万维网
作者
Leonardo de Barros Oliveira,Marcelo Porto Sousa,Gabriel Semione,Márcio Yuri Ferreira,Sávio Batista,Lucca B. Palavani,Filipi Fim Andreão,Jordana Borges Camargo Diniz,Ní­collas Nunes Rabelo,Raphael Bertani,Leonardo C. Welling,Michael T. Lawton,Eberval Gadelha Figueiredo‬‬‬
出处
期刊:World Neurosurgery [Elsevier BV]
卷期号:185: 403-416.e7
标识
DOI:10.1016/j.wneu.2024.02.153
摘要

When traditional therapies are unsuitable, revascularization becomes essential for managing posterior inferior cerebellar artery (PICA) or vertebral artery aneurysms. Notably, the PICA-PICA bypass has emerged as a promising option, overshadowing the occipital artery-PICA (OA-PICA) bypass. To compare the safety and efficacy of OA-PICA and PICA-PICA bypasses. Following PRISMA guidelines, we conducted a systematic review and meta-analysis to evaluate the safety and efficacy of OA-PICA and PICA-PICA bypasses for treating posterior circulation aneurysms. We analyzed 13 studies for the PICA-PICA bypass and 16 studies on the OA-PICA bypass, involving 84 and 110 patients, respectively. The median average follow-up for PICA-PICA bypass was 8 months (2 - 50.3 months), while for OA-PICA, it was 27.8 months (6 - 84 months). The patency rate for OA-PICA was 97% (95% CI: 92% - 100%) and 100% (95% CI: 95% - 100%) for PICA-PICA. Complication rates were 29% (95% CI: 10% - 47%) for OA-PICA and 12% (95% CI: 3% - 21%) for PICA-PICA. Good clinical outcomes were observed in 71% (95% CI: 52% - 90%) of OA-PICA patients and 87% (95% CI: 75% - 100% of PICA-PICA patients. Procedure-related mortality was 1% (95% CI: 0% - 6%) for OA-PICA and 1% (95% CI: 0% - 10%) for PICA-PICA. Both procedures have demonstrated promising results in efficacy and safety. PICA-PICA exhibits slightly better patency rates, better clinical outcomes, and fewer complications, but with a lack of substantial follow-up and a smaller sample size. The choice between these procedures should be based on the surgeon's expertise and the patient's anatomy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
隐形初曼发布了新的文献求助30
1秒前
调皮的皮皮虾完成签到,获得积分10
1秒前
1秒前
2秒前
lightman完成签到,获得积分10
2秒前
dxzdxj发布了新的文献求助10
4秒前
4秒前
wwawi完成签到,获得积分10
5秒前
ixueyi发布了新的文献求助200
5秒前
二等兵佐德完成签到,获得积分10
5秒前
6秒前
王田华完成签到 ,获得积分10
6秒前
华仔的应助被DearSherry采纳,获得10
6秒前
科研通AI6.2的应助被摇摇七喜采纳,获得10
6秒前
自由寻冬完成签到,获得积分10
8秒前
8秒前
8秒前
QZJ666完成签到,获得积分10
8秒前
Jasper的应助被缓慢如曼采纳,获得10
8秒前
酷波er的应助被缓慢如曼采纳,获得10
8秒前
CipherSage的应助被缓慢如曼采纳,获得10
9秒前
慕青的应助被缓慢如曼采纳,获得10
9秒前
9秒前
9秒前
Jasper的应助被缓慢如曼采纳,获得10
9秒前
9秒前
领导范儿的应助被缓慢如曼采纳,获得10
9秒前
9秒前
酷波er的应助被缓慢如曼采纳,获得10
10秒前
深情安青的应助被缓慢如曼采纳,获得10
10秒前
kkm发布了新的文献求助10
10秒前
爆米花的应助被缓慢如曼采纳,获得10
10秒前
科研通AI6.4的应助被缓慢如曼采纳,获得10
10秒前
在水一方的应助被小亿采纳,获得10
11秒前
11秒前
HW完成签到 ,获得积分10
12秒前
隐形初曼完成签到,获得积分10
12秒前
12秒前
Amanda发布了新的文献求助10
13秒前
14秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Yugoslavia and China Histories, Legacies, Afterlives 560
A Silent Apostrophe:The Fayum Portraits 520
Organizational Behavior 510
AI-Contracting 300
四川大学学位论文.郭瑞昂. 基于高压热扩散的n型磷掺杂金刚石半导体制备研究 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7836494
求助须知:如何正确求助?哪些是违规求助? 9358689
关于积分的说明 20605621
捐赠科研通 7429537
什么是DOI,文献DOI怎么找? 3338116
关于科研通互助平台的介绍 2482406
邀请新用户注册赠送积分活动 2359304